[
  {
    "title": "A股异动 | 康为世纪涨逾4% 幽门螺杆菌核酸检测试剂盒取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/23095437233357.shtml",
    "datetime": "2022-12-23 09:54:28",
    "code": "688426"
  },
  {
    "title": "康为世纪：幽门螺杆菌核酸检测试剂盒获医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/22173037231814.shtml",
    "datetime": "2022-12-22 17:30:36",
    "code": "688426"
  },
  {
    "title": "康为世纪(688426.SH)：幽门螺杆菌核酸检测试剂盒取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/22171237231770.shtml",
    "datetime": "2022-12-22 17:12:41",
    "code": "688426"
  },
  {
    "title": "疫情助推业绩激增，达科为、康为世纪等扎堆上市引质疑，沪深交易所：坚持从严审核",
    "href": "http://stock.jrj.com.cn/2022/11/23182437161326.shtml",
    "datetime": "2022-11-23 18:24:26",
    "code": "688426"
  },
  {
    "title": "三只新股上市，康为世纪、瑞晨环保破发",
    "href": "http://stock.jrj.com.cn/2022/10/25093237080525.shtml",
    "datetime": "2022-10-25 09:32:36",
    "code": "688426"
  },
  {
    "title": "康为世纪(688426.SH)将于10月25日在科创板上市",
    "href": "http://stock.jrj.com.cn/2022/10/23153237075620.shtml",
    "datetime": "2022-10-23 15:32:16",
    "code": "688426"
  },
  {
    "title": "康为世纪(688426.SH)披露发行结果：遭弃购26.6718万股、由主承销商包销",
    "href": "http://stock.jrj.com.cn/2022/10/19192437067927.shtml",
    "datetime": "2022-10-19 19:24:16",
    "code": "688426"
  },
  {
    "title": "康为世纪(688426.SH)：中信证券投资获配93.1611万股、网上摇号中签号共16065个",
    "href": "http://stock.jrj.com.cn/2022/10/17191637061492.shtml",
    "datetime": "2022-10-17 19:16:11",
    "code": "688426"
  },
  {
    "title": "10月14日新股申购：麒麟信安、康为世纪、隆扬电子、箭牌家居",
    "href": "http://stock.jrj.com.cn/ipo/2022/10/14075637054548.shtml",
    "datetime": "2022-10-14 07:56:42",
    "code": "688426"
  },
  {
    "title": "IPO打新观察：康为世纪发行市盈率超行业平均，均成资产网下报出87.14元/股最高价",
    "href": "http://stock.jrj.com.cn/ipo/2022/10/13105137052144.shtml",
    "datetime": "2022-10-13 10:51:19",
    "code": "688426"
  },
  {
    "title": "康为世纪(688426.SH)IPO定价为48.98元/股 10月14日开启申购",
    "href": "http://stock.jrj.com.cn/2022/10/12201037051105.shtml",
    "datetime": "2022-10-12 20:10:35",
    "code": "688426"
  },
  {
    "title": "新动态！康为世纪科创板IPO提交注册",
    "href": "http://stock.jrj.com.cn/2022/06/01103436695887.shtml",
    "datetime": "2022-06-01 10:34:35",
    "code": "688426"
  },
  {
    "title": "科创板IPO | 康为世纪、信科移动科创板IPO首发事项过审",
    "href": "http://stock.jrj.com.cn/2022/05/11094336630644.shtml",
    "datetime": "2022-05-11 09:43:16",
    "code": "688426"
  },
  {
    "title": "康为世纪乘“核酸检测”东风闯关IPO：报告期核心高管违反《公司法》任职拷问企业治理 “无证”测检十万",
    "href": "http://stock.jrj.com.cn/ipo/2022/05/10134136619048.shtml",
    "datetime": "2022-05-10 13:41:15",
    "code": "688426"
  },
  {
    "title": "收入核查、股份支付等被追问，康为世纪答复科创板IPO二轮问询",
    "href": "http://stock.jrj.com.cn/2022/04/22104736427043.shtml",
    "datetime": "2022-04-22 10:47:07",
    "code": "688426"
  },
  {
    "title": "中止审核情形消除，康为世纪科创板IPO恢复审核",
    "href": "http://stock.jrj.com.cn/2022/03/30100136183862.shtml",
    "datetime": "2022-03-30 10:01:09",
    "code": "688426"
  },
  {
    "title": "康为世纪首答科创板问询18连问，经营合规性、债转股等被关注",
    "href": "http://stock.jrj.com.cn/2021/12/30111234086005.shtml",
    "datetime": "2021-12-30 11:12:05",
    "code": "688426"
  },
  {
    "title": "康为世纪科创板IPO获问询，新冠疫情“拉升”业绩能否持续？",
    "href": "http://stock.jrj.com.cn/2021/11/01112833796125.shtml",
    "datetime": "2021-11-01 11:28:04",
    "code": "688426"
  },
  {
    "title": "康为世纪冲刺科创板上市，受益新冠业务业绩增长能否持续？",
    "href": "http://stock.jrj.com.cn/2021/10/08095933656054.shtml",
    "datetime": "2021-10-08 09:59:07",
    "code": "688426"
  }
]